Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection
Amyotrophic Lateral Sclerosis in Northern Spain 46 Years Later: What Has Changed?
Amyotrophic lateral sclerosis and richness: A correlation study across Spain
Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study
Amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD)
Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases
Amyotrophic Lateral Sclerosis-Linked Mutant VAPB Inclusions Do Not Interfere with Protein Degradation Pathways or Intracellular Transport in a Cultured Cell Model
Amyotrophic Lateral Sclerosis: Update on Etiological Treatment
Amyotrophic lateral sclerosis after embolization of cerebral arterioveneous malformations
Amyotrophic Lateral Sclerosis: From Research to Therapeutic Attempts and Therapeutic Perspectives
Amyotrophic lateral sclerosis - looking for pathogenesis and effective therapy
Amyotrophic Lateral Sclerosis and Skeletal Muscle: An Update
Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria
Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons
Amyotrophic lateral sclerosis-linked mutant VAPB enhances TDP-43-induced motor neuronal toxicity
Amyotrophic lateral sclerosis, frontotemporal lobar dementia, and p62 A functional convergence?
Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum
Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis: A Genetic Point of View
Amyotrophic lateral sclerosis and the clinical potential of dexpramipexole
Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis as a complex genetic disease
Amyotrophic lateral sclerosis: From current developments in the laboratory to clinical implications
Amyotrophic Lateral Sclerosis: An update for 2013 Clinical Features, Pathophysiology, Management and Therapeutic Trials
Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era
Amyotrophic lateral sclerosis: A neurovascular disease
Amyotrophic lateral sclerosis. Current clinical trials and underlying pathomechanisms
Amyotrophic lateral sclerosis from bench to bedside
Amyotrophic Lateral Sclerosis-Plus Syndrome With TAR DNA-Binding Protein-43 Pathology
Amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis: an update
Amyotrophic lateral sclerosis in Piedmont (Italy): A Bayesian spatial analysis of the incident cases
Amyotrophic Lateral Sclerosis-Like Conditions in Possible Association with Cholesterol-Lowering Drugs An Analysis of Patient Reports to the University of California, San Diego (UCSD) Statin Effects Study
Amyotrophic lateral sclerosis linked to a novel SOD1 mutation with muscle mitochondrial dysfunction
Amyotrophic Lateral Sclerosis Multiprotein Biomarkers in Peripheral Blood Mononuclear Cells
Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene
Amyotrophic Lateral Sclerosis: Drug Therapy from the Bench to the Bedside
Amyotrophic lateral sclerosis and frontotemporal dementia
Amyotrophic Lateral Sclerosis Onset Is Influenced by the Burden of Rare Variants in Known Amyotrophic Lateral Sclerosis Genes
Amyotrophic lateral sclerosis and spinocerebellar ataxia 2
Amyopathic Dermatomyositis: Definitions, Diagnosis, and Management
Amyotrophic Lateral Sclerosis Is Associated with Hypolipidemia at the Presymptomatic Stage in Mice
Amyotrophic Lateral Sclerosis and Agricultural Environments: A Systematic Review
Amyotrophic Lateral Sclerosis and Excitotoxicity: From Pathological Mechanism to Therapeutic Target
Amyotrophic Lateral Sclerosis and Organ Donation: Is There Risk of Disease Transmission?
Amyotrophic Lateral Sclerosis Pathophysiology, Diagnosis and Management
Amyotrophic lateral sclerosis and riluzole use during pregnancy: A case report
Amyotrophic lateral sclerosis in pregnancy is associated with a vascular endothelial growth factor promoter genotype
Amyotrophic lateral sclerosis, enteral nutrition and the risk of iron overload
Amyopathic dermatomyositis developing rapidly progressive interstitial lung disease with elevation of anti-CADM-140/MDA5 autoantibodies
Amyotrophic lateral sclerosis-immunoglobulins selectively interact with neuromuscular junctions expressing P/Q-type calcium channels
Amyotrophic lateral sclerosis immunoglobulins G enhance the mobility of Lysotracker-labelled vesicles in cultured rat astrocytes
Amyotrophic Lateral Sclerosis Risk for Spinocerebellar Ataxia Type 2 ATXN2 CAG Repeat Alleles A Meta-analysis
Amyotrophic Lateral Sclerosis in a Palliative Hospice Care Setting - a Case Report
Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence?
Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of CreutzfeldtJakob disease (CJD)? A case report
Amyotrophic lateral sclerosis-linked mutations increase the viscosity of liquid-like TDP-43 RNP granules in neurons
Amyotrophic lateral sclerosis disease modifying therapeutics: a cell biological perspective
Amyotrophic lateral sclerosis, gene deregulation in the anterior horn of the spinal cord and frontal cortex area 8: implications in frontotemporal lobar degeneration
Amyotrophic lateral sclerosis with frontotemporal dementia (ALS-FTD) syndrome as a phenotype of Creutzfeldt-Jakob disease (CJD)? A case
Amyotrophic lateral sclerosis with long lasting disease course and SOD1 and TARDBP mutations: Report of two cases and overview of the literature
Amyotrophic lateral sclerosis: Is the spinal fluid pathway involved in seeding and spread?
Amyotrophic lateral sclerosis models derived from human embryonic stem cells with different superoxide dismutase 1 mutations exhibit differential drug responses
Amyophatic dermatomyositis presenting as a flagellated skin eruption with positive MDA5 antibodies and thyroid cancer: a real association?
Amyotrophic lateral sclerosis: Current perspectives from basic research to the clinic
Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor
Amyotrophic lateral sclerosis-associated mutant profilin 1 increases dendritic arborisation and spine formation in primary hippocampal neurons
Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms
Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis-like superoxide dismutase 1 proteinopathy is associated with neuronal loss in Parkinson%26apos;s disease brain
Amyotrophic dermatomyositis
Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14-3-3-mediated cell survival by sequestration into the JUNQ compartment
Amyotrophic Lateral Sclerosis, a Multisystem Pathology: Insights into the Role of TNF alpha
Amyotrophic Lateral Sclerosis REPLY
Amyotrophic lateral sclerosis modifies progenitor neural proliferation in adult classic neurogenic brain niches
Amyotrophic Lateral Sclerosis: Precise Diagnosis and Individualized Treatment
Amyotrophic lateral sclerosis and palliative care: Where we are, and the road ahead
Amyotrophic lateral sclerosis affects cortical and subcortical activity underlying motor inhibition and action monitoring
Amyotrophic lateral sclerosis, channelopathies and peripheral neuropathies: current status and new perspectives
Amyotrophic lateral sclerosis: New concept and strategies for a heteregeneous entity
Amyotrophic Lateral Sclerosis Risk for Spinocerebellar Ataxia Type 2 ATXN2 CAG Repeat Alleles A Meta-analysis (vol 71, pg 1529, 2014)
Amyotrophic Lateral Sclerosis: What Role Does Environment Play?
Amyotrophic Lateral Sclerosis Model Derived from Human Embryonic Stem Cells Overexpressing Mutant Superoxide Dismutase 1